JD Health International Inc banner

JD Health International Inc
HKEX:6618

Watchlist Manager
JD Health International Inc Logo
JD Health International Inc
HKEX:6618
Watchlist
Price: 46.04 HKD -0.6% Market Closed
Market Cap: HK$147.4B

EV/OCF

10
Current
38%
Cheaper
vs 3-y average of 16.2

Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.

EV/OCF
10
=
Enterprise Value
HK$104B
/
Operating Cash Flow
¥8.3B

Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.

EV/OCF
10
=
Enterprise Value
HK$104B
/
Operating Cash Flow
¥8.3B

Valuation Scenarios

JD Health International Inc is trading below its 3-year average

If EV/OCF returns to its 3-Year Average (16.2), the stock would be worth HK$74.78 (62% upside from current price).

Statistics
Positive Scenarios
4/4
Maximum Downside
No Downside Scenarios
Maximum Upside
+108%
Average Upside
83%
Scenario EV/OCF Value Implied Price Upside/Downside
Current Multiple 10 HK$46.04
0%
3-Year Average 16.2 HK$74.78
+62%
5-Year Average 19.1 HK$88.04
+91%
Industry Average 17.1 HK$78.69
+71%
Country Average 20.8 HK$95.89
+108%

Forward EV/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward EV/OCF

Peer Comparison

All Multiples
EV/OCF
P/E
All Countries
Close
Market Cap EV/OCF P/E
CN
JD Health International Inc
HKEX:6618
147.4B HKD 10 24.2
US
Amazon.com Inc
NASDAQ:AMZN
2.8T USD 19.7 36.1
ZA
Naspers Ltd
JSE:NPN
708B ZAR 18.8 7.6
CN
Alibaba Group Holding Ltd
NYSE:BABA
316.2B USD 22 23.4
CN
PDD Holdings Inc
NASDAQ:PDD
139.8B USD 5 9.7
NL
Prosus NV
AEX:PRX
97B EUR 63.2 8.5
UY
MercadoLibre Inc
BMV:MELIN
1.6T MXN 7.5 46.3
AR
Mercadolibre Inc
NASDAQ:MELI
92.8B USD 7.5 46.5
US
DoorDash Inc
NASDAQ:DASH
75.6B USD 30.2 80.9
CN
Meituan
HKEX:3690
503.9B HKD -26.3 -19.3
CN
JD.Com Inc
HKEX:9618
376.8B HKD 9.3 16.7
P/E Multiple
Earnings Growth PEG
CN
JD Health International Inc
HKEX:6618
Average P/E: 30
24.2
22%
1.1
US
Amazon.com Inc
NASDAQ:AMZN
36.1
19%
1.9
ZA
N
Naspers Ltd
JSE:NPN
7.6
1%
7.6
CN
Alibaba Group Holding Ltd
NYSE:BABA
23.4
11%
2.1
CN
PDD Holdings Inc
NASDAQ:PDD
9.7
16%
0.6
NL
Prosus NV
AEX:PRX
8.5
4%
2.1
UY
MercadoLibre Inc
BMV:MELIN
46.3
36%
1.3
AR
Mercadolibre Inc
NASDAQ:MELI
46.5
37%
1.3
US
D
DoorDash Inc
NASDAQ:DASH
80.9
47%
1.7
CN
Meituan
HKEX:3690
Negative Multiple: -19.3 N/A N/A
CN
JD.Com Inc
HKEX:9618
16.7
8%
2.1

Market Distribution

Lower than 74% of companies in China
Percentile
26th
Based on 6 190 companies
26th percentile
10
Low
0 — 11.5
Typical Range
11.5 — 39.2
High
39.2 —
Distribution Statistics
China
Min 0
30th Percentile 11.5
Median 20.8
70th Percentile 39.2
Max 266 666.7

JD Health International Inc
Glance View

Market Cap
147.4B HKD
Industry
Retail

JD Health International Inc., a significant arm of the Chinese e-commerce giant JD.com, emerges as a leading force in the digital healthcare landscape. It operates by seamlessly blending technology with healthcare services, providing a multitude of solutions designed to cater to the diverse needs of its users. They have harnessed the power of the internet to offer online medical consultations, a service that connects patients with a network of licensed healthcare professionals. This innovative approach not only broadens access to medical advice and care but also disrupts traditional healthcare models by emphasizing convenience and accessibility. By utilizing advanced algorithms and AI technology, JD Health also offers personalized health management, positioning itself as a pivotal participant in the quest for enriched digital health experiences. The revenue model of JD Health is underpinned by its multifaceted ecosystem, primarily driven by the sale of pharmaceutical products, healthcare merchandise, and the provision of online medical services. They employ a B2C strategy that accounts for most of their sales, utilizing JD.com’s expansive logistics network to ensure swift and reliable delivery. Additionally, the company monetizes its platform by offering premium health-related content and services on a subscription basis, appealing to a broad audience eager to embrace new healthcare paradigms. As the digital transformation of healthcare accelerates, JD Health strategically positions itself to benefit from an expanding market, leveraging its technological expertise and comprehensive service offerings to make healthcare more accessible and efficient for its growing user base.

Intrinsic Value
57.19 HKD
Undervaluation 20%
Intrinsic Value
Price HK$46.04
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett